Browsing 1 studies for William Rieter
PSMAddition: An International Prospective Open-label, Randomized, Phase III Study comparing 177Lu-PSMA-617 in combination with Standard of Care, versus Standard of Care alone, in adult male patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
- Date Added
- February 25th, 2022
- PRO Number
- Pro00115899
- Researcher
-
William Rieter
List of Studies